BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Deloitte
Cipla
Fish and Richardson
AstraZeneca
Accenture
QuintilesIMS
Teva
Boehringer Ingelheim

Generated: January 21, 2018

DrugPatentWatch Database Preview

PARICALCITOL - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for paricalcitol and what is the scope of paricalcitol patent protection?

Paricalcitol
is the generic ingredient in two branded drugs marketed by Amneal Pharms, Aurobindo Pharma Ltd, Bionpharma Inc, Dr Reddys Labs Ltd, Eci Pharms Llc, Marksans Pharma, Rising Pharms Inc, Teva Pharms Usa, Abbvie, Accord Hlthcare, Akorn, Amneal Pharms Co, Hikma Pharms, Hospira Inc, Mylan Labs Ltd, and Sandoz Inc, and is included in eighteen NDAs. There are two patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Paricalcitol has seventeen patent family members in ten countries.

There are ten drug master file entries for paricalcitol. Twenty suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for PARICALCITOL
Ingredient-typeCholecalciferol
Drug ClassVitamin D3 Analog
Tentative approvals for PARICALCITOL
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe2MCG/MLINJECTABLE; INJECTION
➤ Subscribe➤ Subscribe10MCG/MLINJECTABLE; INJECTION
➤ Subscribe➤ Subscribe5MCG/MLINJECTABLE; INJECTION

US Patents and Regulatory Information for PARICALCITOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising Pharms Inc PARICALCITOL paricalcitol CAPSULE;ORAL 202124-001 Jun 24, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-002 May 26, 2005 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd PARICALCITOL paricalcitol CAPSULE;ORAL 091412-003 Jun 24, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa PARICALCITOL paricalcitol CAPSULE;ORAL 090829-001 Sep 27, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 091108-002 Jul 27, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-002 Feb 1, 2000 AP RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bionpharma Inc PARICALCITOL paricalcitol CAPSULE;ORAL 202539-003 Mar 27, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-002 May 26, 2005 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms PARICALCITOL paricalcitol CAPSULE;ORAL 204327-001 Jan 13, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Marksans Pharma PARICALCITOL paricalcitol CAPSULE;ORAL 204948-002 Oct 7, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PARICALCITOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-001 Apr 17, 1998 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-002 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-003 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-001 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-003 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-002 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-002 Feb 1, 2000 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-001 Apr 17, 1998 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-001 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-002 Feb 1, 2000 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for PARICALCITOL

Supplementary Protection Certificates for PARICALCITOL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB04/003 United Kingdom ➤ Subscribe PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
US Army
Boehringer Ingelheim
Harvard Business School
Dow
Julphar
McKinsey
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot